Your child will be cared for by one of the most accomplished teams of bleeding disorder experts in the world. We make sure your child and every member of your family get the highest level of support.
Researchers at Children’s Hospital of Philadelphia (CHOP) found that emicizumab, a widely used drug for hemophilia A, could also improve blood clotting for select people with hemophilia B depending on their genes. The preclinical study, recently published in Blood, offers proof that this class of hemophilia A drug could potentially be used to treat hemophilia B.
Jun 7, 2023
A look back at the last five decades of treatment options to what lies ahead with additional potentially curative gene therapies.
Feb 23, 2023
CHOP gene therapy expert Dr. Lindsey George reacts to a phase 3 hemophilia gene therapy study in an editorial in the New England Journal of Medicine.
Dec 22, 2022
CHOP experts in bleeding disorders care and research presented at the American Society of Hematology 2022 conference.